Lithuania-Kaunas: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Opportunity Score
Confidence: 60%
Complexity: medium
—
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This is a Dynamic Purchasing System (DPS) for a wide range of medicinal products, established by Kauno klinikos (Lithuania). The DPS covers general anti-infectives, vaccines, antineoplastic agents, immunomodulators, and several other therapeutic categories. The procedure is restricted, with award based on the lowest price. The total estimated value is EUR 11,428,571.43. Initial applications must be submitted by 7 February 2022, but the DPS remains open for new applications throughout its 60-month duration.
Strengths
Medium complexity
Risks
Restricted procedure — pre-qualification required
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Submission of ESPD (European Single Procurement Document)
- Valid license to engage in pharmaceutical activities (or equivalent for non-Lithuanian suppliers)
- Submission in Lithuanian language
Buyer
Name
Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos
Location
Kaunas, LTU
Website
Identifier
135163499
Lots (1)
DPS covering medicinal products including: systemic anti-infectives, vaccines, antineoplastics, immunomodulators, alimentary tract and metabolism products, blood and cardiovascular products, dermatological and musculo-skeletal products, genitourinary system and hormones, nervous system and sensory organs products, respiratory system products, and various other medicinal products.
Procurement Details
Publication
04 Jan 2022
Deadline
—
Procedure
restricted
Contract
supplies
Language
LIT
Publication #
4329-2022
Classification
Opportunity Score
Confidence: 60%
Complexity: medium
—
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation